DEVONIAN HEALTH GROUP INC (GSD.CA) Stock Balance Sheet
Canada - TSX Venture Exchange - TSX-V:GSD - CA2518348008 - Common Stock
0.2 CAD
-0.02 (-9.09%)
| 2025 (2025-7-31) | 2024 (2024-7-31) | 2023 (2023-7-31) | 2022 (2022-7-31) | 2021 (2021-7-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 6.98M | 9.86M | 5.06M | 2.81M | 344.80K | |||
| Marketable Securities | N/A | N/A | 0.00 | 5.00M | N/A | |||
| Receivables | 1.50M | 8.12M | 940.80K | 337.20K | 235.10K | |||
| Inventories | 34.50K | 60.90K | 159.80K | 154.60K | 28.20K | |||
| Other Current Assets | 203.40K | 416.20K | 181.50K | 120.20K | 56.20K | |||
| Total Current Assets | 8.72M | 18.46M | 6.34M | 8.42M | 664.20K | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.20M | 2.50M | 2.68M | 2.88M | 3.07M | |||
| Goodwill | 0.00 | 4.64M | 4.64M | 4.64M | 4.64M | |||
| Intangibles | 4.90M | 5.13M | 5.51M | 5.64M | 6.23M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 7.11M | 12.27M | 12.83M | 13.17M | 13.94M | |||
| TOTAL ASSETS | 15.83M | 30.73M | 19.18M | 21.59M | 14.61M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 47.70K | 2.12M | 3.60M | 6.00K | 4.60K | |||
| Accrued Expenses | 2.18M | 10.06M | 502.20K | 624.70K | N/A | |||
| Accounts Payable | N/A | N/A | N/A | N/A | 1.81M | |||
| Other Current Liabilities | 4.39M | 4.56M | 753.60K | 410.40K | N/A | |||
| Total Current Liabilities | 6.61M | 16.75M | 4.86M | 1.04M | 1.81M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 78.20K | 125.70K | 72.60K | 4.27M | 5.27M | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 78.10K | 125.80K | 72.50K | 4.27M | 5.27M | |||
| TOTAL LIABILITIES | 6.69M | 16.87M | 4.93M | 5.31M | 7.08M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -30.23M | -24.32M | -18.86M | -14.98M | -16.07M | |||
| Additional Paid In Capital | 8.93M | 8.34M | 3.76M | 3.68M | 3.39M | |||
| Common Shares | 30.44M | 29.84M | 29.35M | 27.57M | 20.21M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 148.22M | 148.22M | 144.46M | 131.14M | 93.46M | |||
| Tangible Book Value per Share | 0.03 | 0.03 | 0.03 | 0.05 | -0.04 | |||
| Total Shareholders' Equity | 9.14M | 13.86M | 14.25M | 16.27M | 7.52M | |||
| TOTAL LIABILITIES AND EQUITY | 15.83M | 30.73M | 19.18M | 21.59M | 14.61M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | 0.01 | 0.26 | 0.70 | |||
| Current Ratio | 1.32 | 1.10 | 1.31 | 8.08 | 0.37 | |||
| Return On Assets (ROA) | -37.98% | -5.94% | -23.98% | -15.97% | -22.91% | |||
| Return On Equity (ROE) | -65.80% | -13.18% | -32.28% | -21.19% | -44.48% | |||
All data in CAD , ROIC based on taxRate of 0.28